XELJANZ - TOFACITINIB CITRATE
Navigation: NDC > Supplier starting with: U > U.S. PHARMACEUTICALS| Field | Value |
|---|---|
| NDC Code: | 63539-012 |
| Proprietary Name: | XELJANZ |
| Suffix: | |
| Non-Proprietary Name: | TOFACITINIB CITRATE |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 08-11-2012 |
| Category Name: | NDA |
| Application Number: | NDA203214 |
| Labeler: | U.S. PHARMACEUTICALS |
| Substance Name: | TOFACITINIB CITRATE |
| Active Numerator Strength: | 5 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | |
| DEA Schedule: |